Try Sinofresh for bacterial sinus and MRSA infections
Sinofresh Healthcare products : Easy treatment for bacterial and chronic sinus infection

Company Info
Background
Management Team
Press Releases
Medical Papers
 

Investor Relations
SEC Filings
Shareholder Info
 

Sinofresh healthcare - A remedy for rhinosinusitis

Medical Paper Papers

1: Am J Rhinol. 2003 Jan-Feb;17(1):9-15.

Microbiology of middle meatus in chronic rhinosinusitis.

Araujo E, Palombini BC, Cantarelli V, Pereira A, Mariante A.

Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

BACKGROUND: Nasal endoscopy allows the collection of middle meatus secretion samples and is an alternative method for determining microorganisms in rhinosinusitis. This study assessed endoscopically collected middle meatus secretions in patients with chronic rhinosinusitis (CRS) and compared those findings with ipsilateral maxillary sinus aspirates and microbiological data of healthy individuals.

METHODS: Middle meatus samples were collected from 114 CRS patients for aerobic, anaerobic, and fungal cultures; maxillary sinus secretions were collected from 13 of these patients. Twenty-three healthy volunteers served as controls. RESULTS: Aerobes were isolated in 86% of CRS patients, anaerobes were isolated in 8% of CRS patients, and fungi were isolated in 11% of CRS patients; the most frequent microorganisms were Staphylococcus aureus (36%), coagulase-negative Staphylococcus (20%), and Streptococcus pneumoniae (17%). Middle meatus and maxillary sinus cultures presented the same pathogens in 80% of cases. In healthy individuals, coagulase-negative Staphylococcus (56%), S. aureus (39%), and S. pneumoniae (9%) were the most frequent isolates.

CONCLUSION: The culture of endoscopically collected middle meatus secretions is effective in identifying microorganisms in CRS patients.

Publication Types:
  • Evaluation Studies

PMID: 12693650 [PubMed - indexed for MEDLINE]

 
©2011 SinoFresh HealthCare, Inc. All rights reserved.

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy and our Terms of Use. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy and to our Terms of Use Agreement. Your use of the information on this site is subject to our Terms of Use Agreement and the legal notices contained therein. You should review the Press Release section and the most recent SEC filings in the Investor Relations section in order to receive the most current information made available by SinoFresh HealthCare, Inc.